DISA (SGX:532) has entered into a non-binding agreement to acquire 50% of an operator of a rheumatism and arthritis specialist medical center, according to a Monday filing on the Singapore Exchange.

The SG$5.5 million proposed acquisition involves a cash payment of SG$3 million and SG$2.5 million in newly issued DISA shares, priced at either the prevailing market price or a minimum that will be determined later.

The target company, established in 2003, is Singapore's only heartland-based center specializing in arthritis and rheumatism care, with FY24 revenue of SG$7.6 million and EBITDA of SG$2.1 million.

Completion depends on due diligence, funding, and approvals, with the seller committing to a 10-year practitioner role and maintaining a 50% stake.